PF-06726304 acetate, with the CAS number 2080306-28-9, is a chemical compound that belongs to the class of small molecule inhibitors. It is primarily characterized by its role as a selective inhibitor of certain protein kinases, which are crucial in various cellular signaling pathways. This compound is often studied in the context of cancer research and other diseases where aberrant kinase activity is implicated. PF-06726304 acetate is typically administered in a form that enhances its solubility and bioavailability, making it more effective in therapeutic applications. Its molecular structure includes functional groups that contribute to its binding affinity and specificity for target kinases. Additionally, the acetate moiety can influence the pharmacokinetic properties of the compound, such as absorption and distribution within biological systems. Overall, PF-06726304 acetate represents a promising candidate in the development of targeted therapies, with ongoing research aimed at elucidating its full therapeutic potential and safety profile.

PF-06726304 acetate

2080306-28-9: PF-06726304 acetate, with the CAS number 2080306-28-9, is a chemical compound that belongs to the class of small molecule inhibitors. It is primarily characterized by its role as a selective inhibitor of certain protein kinases, which are crucial in various cellular signaling pathways. This compound is often studied in the context of cancer research and other diseases where aberrant kinase activity is implicated. PF-06726304 acetate is typically administered in a form that enhances its solubility and bioavailability, making it more effective in therapeutic applications. Its molecular structure includes functional groups that contribute to its binding affinity and specificity for target kinases. Additionally, the acetate moiety can influence the pharmacokinetic properties of the compound, such as absorption and distribution within biological systems. Overall, PF-06726304 acetate represents a promising candidate in the development of targeted therapies, with ongoing research aimed at elucidating its full therapeutic potential and safety profile.

<p>PF-06726304 acetate is a selective inhibitor of EZH2, with robust antitumor growth activity.</p>

CAS 2080306-28-9

PF-06726304 acetate

PF-06726304 acetate

Ref: TM-T12428